Additionally, it examined the expression of CCR3, CCL11, IL-5Rα, and TLRs in TA-treated normal and colitis mice to evaluate the role of TA in enhancing eosinophil-mediated inflammation through the modulation of these receptors and ligands. This evidence concerns the gene IL5RA and colitis.